Swarna Bhasma in cancer: A prospective clinical study

Despite the advances in the treatment of cancer, mortality is still high. Complementary and alternative medicine is emerging as a potent modality in cancer treatment. ‘Swarna Bhasma’ (SB), containing gold particles, is an ancient Indian medicine has shown its anticancer activity. This present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Soumen, Das, Mangal C., Paul, Retina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665104/
https://www.ncbi.nlm.nih.gov/pubmed/23723642
http://dx.doi.org/10.4103/0974-8520.108823
_version_ 1782271208542175232
author Das, Soumen
Das, Mangal C.
Paul, Retina
author_facet Das, Soumen
Das, Mangal C.
Paul, Retina
author_sort Das, Soumen
collection PubMed
description Despite the advances in the treatment of cancer, mortality is still high. Complementary and alternative medicine is emerging as a potent modality in cancer treatment. ‘Swarna Bhasma’ (SB), containing gold particles, is an ancient Indian medicine has shown its anticancer activity. This present study was conducted to detect the effect of SB on solid malignancies. A total of 43 patients were included in this study received SB for 1 year. Seventeen patients showed response. The response was best in rectal cancer group 70% (7/10). Nearly 41.02% patients survived for 1 year after treatment but after 5 years this came down to 15.38%.
format Online
Article
Text
id pubmed-3665104
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36651042013-05-30 Swarna Bhasma in cancer: A prospective clinical study Das, Soumen Das, Mangal C. Paul, Retina Ayu Clinical Research Despite the advances in the treatment of cancer, mortality is still high. Complementary and alternative medicine is emerging as a potent modality in cancer treatment. ‘Swarna Bhasma’ (SB), containing gold particles, is an ancient Indian medicine has shown its anticancer activity. This present study was conducted to detect the effect of SB on solid malignancies. A total of 43 patients were included in this study received SB for 1 year. Seventeen patients showed response. The response was best in rectal cancer group 70% (7/10). Nearly 41.02% patients survived for 1 year after treatment but after 5 years this came down to 15.38%. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3665104/ /pubmed/23723642 http://dx.doi.org/10.4103/0974-8520.108823 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Das, Soumen
Das, Mangal C.
Paul, Retina
Swarna Bhasma in cancer: A prospective clinical study
title Swarna Bhasma in cancer: A prospective clinical study
title_full Swarna Bhasma in cancer: A prospective clinical study
title_fullStr Swarna Bhasma in cancer: A prospective clinical study
title_full_unstemmed Swarna Bhasma in cancer: A prospective clinical study
title_short Swarna Bhasma in cancer: A prospective clinical study
title_sort swarna bhasma in cancer: a prospective clinical study
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665104/
https://www.ncbi.nlm.nih.gov/pubmed/23723642
http://dx.doi.org/10.4103/0974-8520.108823
work_keys_str_mv AT dassoumen swarnabhasmaincanceraprospectiveclinicalstudy
AT dasmangalc swarnabhasmaincanceraprospectiveclinicalstudy
AT paulretina swarnabhasmaincanceraprospectiveclinicalstudy

Ejemplares similares